C4 Therapeutics Inc.

NASDAQ: CCCC · Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT

C4 Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.37 -2.12 -2.28 -17.23
PEG Ratio
0.06 -0.69 -0.06 -0.8
PS Ratio
7.02 13.51 9.27 32.38
PB Ratio
1.16 1.14 1.00 3.81
P/FCF Ratio
-3.82 -2.58 -2.59 -16.8
P/OCF Ratio
-3.83 -2.63 -2.72 -17.05
OCF/S Ratio
-1.83 -5.15 -3.41 -1.9
Debt / Equity Ratio
0.30 0.29 0.30 0.11
Quick Ratio
5.71 6.34 7.82 6.36
Current Ratio
5.71 6.34 6.46 6.36
Asset Turnover
0.10 0.06 0.07 0.09
Interest Coverage
n/a -101.26 -58.45 -38.29
Return on Equity
-0.49 -0.54 -0.44 -0.22
Return on Assets
-0.3 -0.35 -0.29 -0.17
Return on Invested Capital
-0.39 -0.41 -0.32 -0.18
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -4.67 0.76 0.94
Net Profit Margin
-2.96 -6.38 -4.07 -1.88
Pretax Profit Margin
-2.96 -6.32 -4.12 -1.83
Operating Profit Margin
-3.36 -6.7 -4.17 -1.79
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.9 -5.88 -4 -1.72